Literature DB >> 1587610

Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.

M Ogata1, T Matsumoto, M Kamochi, S I Yoshida, Y Mizuguchi, A Shigematsu.   

Abstract

The leukotrienes and tumor necrosis factor (TNF) play an important role in the pathophysiology of septic shock, in which hypotension, leukopenia, thrombocytopenia, and hemoconcentration are observed. This study was performed to examine the effects of a 5-lipoxygenase inhibitor (AA-861), a selective leukotriene receptor antagonist (ONO-1078), and a cyclooxygenase inhibitor (indomethacin) on endotoxin-induced mortality and TNF production in mice. Mice were injected intraperitoneally with carrageenan (5 mg per mouse), which we previously reported as an effective priming agent for lipopolysaccharide (LPS)-induced TNF production and mortality (M. Ogata, S. Yoshida, M. Kamochi, A. Shigematsu, and Y. Mizuguchi, Infect. Immun. 59:679-683, 1991). The indicated doses of AA-861, ONO-1078, indomethacin, or controls were administrated subcutaneously 30 min before LPS (50 micrograms per mouse) provocation. The mortality of mice was significantly decreased by pretreatment with AA-861 (P less than 0.001) or ONO-1078 (P less than 0.01) but not by pretreatment with indomethacin. The 50% lethal dose of LPS in the mice treated with dimethyl sulfoxide or ethanol was 32 or 33 micrograms, respectively, and it increased to 83 micrograms with AA-861 or 59 micrograms with ONO-1078, respectively. Neither AA-861 nor ONO-1078 suppressed LPS-induced TNF production in sera. Treatment with AA-861 significantly decreased the leukopenia and thrombocytopenia, and ONO-1078 significantly decreased the hemoconcentration and thrombocytopenia. The role of endogenous TNF was also examined in the carrageenan-pretreated mice. Treatment with 2 x 10(5) U of rabbit anti TNF-alpha antibody intravenously 2 h before LPS challenge significantly suppressed the LPS-induced TNF activity and decreased the mortality. Therefore, both leukotrienes and TNF play important roles in endotoxin-induced shock and mortality.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587610      PMCID: PMC257177          DOI: 10.1128/iai.60.6.2432-2437.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice.

Authors:  A K Myers; J W Robey; R M Price
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

Review 2.  The pharmacology and pathophysiology of leukotriene B4.

Authors:  M A Bray
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

3.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats.

Authors:  G Feuerstein; J M Hallenbeck; B Vanatta; R Rabinovici; P Y Perera; S N Vogel
Journal:  Circ Shock       Date:  1990-03

5.  Human tumour necrosis factor-alpha (TNF-alpha) directly stimulates arachidonic acid release in human neutrophils.

Authors:  Y H Atkinson; A W Murray; S Krilis; M A Vadas; A F Lopez
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

6.  Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.

Authors:  T M Saba; E Jaffe
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

7.  Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.

Authors:  A K Franks; K I Kujawa; L J Yaffe
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.

Authors:  J L Rothstein; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

9.  Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.

Authors:  M Ogata; S Yoshida; M Kamochi; A Shigematsu; Y Mizuguchi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis.

Authors:  T Yoshimoto; C Yokoyama; K Ochi; S Yamamoto; Y Maki; Y Ashida; S Terao; M Shiraishi
Journal:  Biochim Biophys Acta       Date:  1982-11-12
View more
  5 in total

1.  Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice.

Authors:  T Matsumoto; M Ogata; K Koga; A Shigematsu
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

2.  Nicotine administration and withdrawal affect survival in systemic inflammation models.

Authors:  Alexandre A Steiner; Daniela L Oliveira; Jennifer L Roberts; Scott R Petersen; Andrej A Romanovsky
Journal:  J Appl Physiol (1985)       Date:  2008-07-10

3.  An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.

Authors:  M Ogata; T Matsumoto; K Koga; I Takenaka; M Kamochi; T Sata; S Yoshida; A Shigematsu
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

4.  Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.

Authors:  K Takada; N Ohno; T Yadomae
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

5.  Cigarette Smoke Exposure Worsens Endotoxin-Induced Lung Injury and Pulmonary Edema in Mice.

Authors:  Jeffrey E Gotts; Jason Abbott; Xiaohui Fang; Haru Yanagisawa; Naoki Takasaka; Stephen L Nishimura; Carolyn S Calfee; Michael A Matthay
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.